AbbVie Inc. (ABBV)
Last Price$198.190.9%
Market Cap$344.8bn
Financial profile score
1/10
LTM Revenue
$55.0 bn
+1.1% YoY
LTM Net Income
$5.3 bn
-10.8% YoY
LTM Free Cash Flow
$17.8 bn
-18.8% YoY
Net Debt
$57.5 bn
Short-term financial position
0.8x
Current Assets / Current Liabilities
ABBV Income statement
Crunching data... Almost there!
Earnings growth (<10% annually)
ABBV's earnings have decreased by -9.1% per year over the past 5 years.
Growing Net income margin
ABBV's net income margin has decreased (-11.4%)
in the last year from (20.4%) to (9.0%)
ABBV Balance sheet
Crunching data... Almost there!
ABBV Key balance sheet metrics
Crunching data... Almost there!
ABBV Cash flow statement
Crunching data... Almost there!
ABBV Key cash flow statement metrics
Crunching data... Almost there!
Growing free cash flow margin
ABBV's free cash flow margin has decreased
(-1.2%)
in the last year from (41.8%) to (40.6%)
Discover more ABBV fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What are AbbVie Inc. (ABBV) Key Income Statement Metrics?
As of today, AbbVie Inc. last 12-month Revenue is $55.0 bn , EBITDA is $16.8 bn and Net Income is $5.3 bn , based on the financial report for June 30, 2024 (Q2 2024).
What are AbbVie Inc. (ABBV) Key Balance Sheet Metrics?
As of today, AbbVie Inc. Total Assets are $141.9 bn and Total Liabilities are $135.1 bn , based on the financial report for June 30, 2024 (Q2 2024).
What are AbbVie Inc. (ABBV) Key Cash Flow Statement Metrics?
As of today, AbbVie Inc. last 12-month Cash Flow from Operating Activities is $2.3 bn, Cash Flow from Investing Activities is $-1.1 bn and Cash Flow from Financing Activities is $-6.1 bn, based on the financial report for June 30, 2024 (Q2 2024).
What is AbbVie Inc. (ABBV) Free Cash Flow?
As of today, AbbVie Inc. last 12-month Free Cash Flow is $17.8 bn , based on the financial report for June 30, 2024 (Q2 2024).